Early days
EnduraX uses conservative fallback paths while the athlete’s history is still building. It does not label a short history as a mature baseline.
Founding access is open for 2026.EnduraX™ is in early access for the 2026 founding cohort. Founding members lock their rate before paid plans arrive in 2027.
DARS · methodology overview
The daily read is designed to make context easier to discuss—not to turn a complex athlete into a universal score.
Methodology overview updated August 22, 2026 · Model behavior can evolve as evidence and product validation improve.
Today’s read
Slightly below your range
The number starts the conversation.
Your normal range—not a population leaderboard
Readiness guidance only. A DARS score is not a diagnosis, injury prediction, treatment recommendation, or medical clearance.
The current composite weights keep the five domains visible. Missing optional data degrades to simpler paths rather than pretending certainty.
Recent work, duration, intensity, and perceived effort are read as training context—not as a standalone injury prediction.
Connected HRV and resting-heart-rate context can supplement how the athlete says they are recovering.
Duration, quality, and supported sleep context are considered against what is normal for the athlete.
Athlete-reported or supported fueling context is read relative to the work being asked of the body.
Protective patterns can lower the daily read and prompt a conversation; they do not diagnose RED-S.
Personal-range philosophy
EnduraX uses conservative fallback paths while the athlete’s history is still building. It does not label a short history as a mature baseline.
Supported recovery biometrics can shift to a personal 28-day comparison after at least 14 days of usable history.
Monitored self-report fields begin personal-deviation analysis after at least 21 days and use a rolling history.
A value outside the range is a reason to look closer. It is not proof that something is wrong, and it is never automatic clearance.
These sources help shape the protective and monitoring philosophy. They do not make DARS itself a validated clinical instrument, and EnduraX does not reproduce a screening questionnaire as a diagnosis.
The limits matter
Wearable gaps, self-report bias, short baselines, illness, medications, device differences, and changing circumstances can all affect the read. Persistent symptoms, pain, or health concerns belong with a qualified professional regardless of score.